RxDoctor Payments Data

Sara Christie

Family · Greenville, SCNPI 1740641877

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $208,378 of the $229,199 with a category attached, or 90.9%. Galderma Laboratories, L.p. accounts for 99.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $85,295 and has fallen 51.6% since, to $41,317 in 2025. Among family clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$229,199in general payments, 2019–2025

Across 324 payments — averaging $707.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$229K
  • AbbVie$384
  • Amgen$58
  • Amarin Pharma, Inc.$40
  • Novo Nordisk$21
  • Takeda Pharmaceuticals U.S.A., Inc.$20

What the payments were for

  • Speaking & faculty fees$208,37891%
  • Travel & lodging$17,4378%
  • Food & beverage$3,3841%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$229,199 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Other family in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →